TRACON Pharmaceuticals Inc (TCON)
1.76
-0.06
(-3.30%)
USD |
NASDAQ |
May 08, 16:00
1.76
0.00 (0.00%)
After-Hours: 07:52
TRACON Pharmaceuticals Profit Margin (Quarterly): 14.42% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.42% |
September 30, 2023 | |
June 30, 2023 | -69.84% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | -2.58K% |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 |
Date | Value |
---|---|
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | -278.8% |
December 31, 2017 | |
September 30, 2017 | 15.60% |
June 30, 2017 | -1.04K% |
March 31, 2017 | -1.14K% |
December 31, 2016 | -1.02K% |
September 30, 2016 | -720.4% |
June 30, 2016 | -1.03K% |
March 31, 2016 | -539.3% |
December 31, 2015 | -791.9% |
September 30, 2015 | -546.4% |
June 30, 2015 | -69.60% |
March 31, 2015 | -352.9% |
December 31, 2014 | -245.1% |
September 30, 2014 | -169.4% |
June 30, 2014 | -91.67% |
March 31, 2014 | -382.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.58K%
Minimum
Jun 2021
14.42%
Maximum
Dec 2023
-879.7%
Average
-69.84%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
BioSig Technologies Inc | -50.41K% |
Revolution Medicines Inc | -21.77K% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 12.23% |
Xtant Medical Holdings Inc | -15.31% |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -30.15% |
Operating Margin (Quarterly) | 91.36% |
Return on Net Operating Assets | -159.5% |